Clinical trial
Comparison of Efficacy and Safety Between Aspirin and Clopidogrel in the Atrial Fibrillation With Low or Moderate Stroke Risk
NCT02960126 is registered in ClinicalTrials.gov with Chuncheon Sacred Heart Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Efficacy and Safety Between Aspirin and Clopidogrel in the Atrial Fibrillation With Low or Moderate Stroke Risk
- Lead sponsor
- Chuncheon Sacred Heart Hospital
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- November 30, 2016
- Completion date
- October 31, 2021
- Enrollment
- 1,500 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.